Navigation Links
Amgen Announces Webcast of 2008 Third Quarter Financial Results
Date:10/20/2008

THOUSAND OAKS, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that it plans to report its third quarter financial results on Wednesday, Oct. 22, 2008 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and CEO, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call, including the question and answer session, is expected to last approximately one hour.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's Web site, http://www.amgen.com, under Investors. Information regarding presentation times, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay 72 hours after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines,
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
4. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
5. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
6. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 Even within a phylum so full of ... among other arthropods for its cruelty -- at least to ... the fly is a most predatory sort of parasite. It ... a smear of larvae, and leaves its wicked brood to ... , None of this would be possible without the fly,s ...
(Date:7/22/2014)... Nuclear reactors are used to produce electricity ... chain reaction in nuclear reactors is used to create ... a power- generating turbine. Currently nuclear reactors are used ... production. Nuclear reactor market is expected to grow in ... nuclear reactor projects. , Early buyers will receive 10% ...
(Date:7/22/2014)... July 22, 2014 Two new members ... of Directors at its annual Shareholders Meeting on June ... Officer of The PFM Group, and Stephen T. Zarrilli, ... also announced the election of Michael A. DiPiano, Managing ... Chair and Richard P. Jaffe, Esq., of Duane Morris ...
(Date:7/22/2014)... en SHENZHEN, China , 22 juli ... Tech), een dochtermaatschappij van BGI, ,s wereld grootste organisatie ... aan van een nieuwe service ten behoeve van hele ... platform van Complete Genomics. In 2013 ... sector in hoog aanzien staat vanwege de in eigen ...
Breaking Biology Technology:Fly-inspired sound detector 2Fly-inspired sound detector 3Fly-inspired sound detector 4Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 2Nuclear Energy Market: Global Industry Analysis, Size, Share, Analysis, Growth and Forecast 2013 - 2019 3Two New Members Elected to University City Science Center Board of Directors 2Two New Members Elected to University City Science Center Board of Directors 3BGI Tech introduceert service op gebied van hele menselijke exoomsequencing op geavanceerd Complete Genomics-platform 2
... Inc. (the "Company",or "SulphCo") (Amex: SUF ), a ... oil, announced today the appointment of Fred,S. Zeidman to ... to have Mr. Zeidman join SulphCo,s Board of Directors,",said ... "The Company,will benefit from his extensive experience, both in ...
... August 28 Strong organic,growth continued in Q2 2008 supported ... diagnostic product based on,miRNA profiling remains on track for year ... by 139% on the year-earlier period to DKK 28 ... of 2008., - Product sales in Q2 2008 increased ...
... Volcano Corporation,(Nasdaq: VOLC ), a leading ... measurement (FM) and Optical Coherence,Tomography (OCT) products ... coronary and peripheral vascular disease, said today ... Weisel Partners 2008 Healthcare Conference on,Thursday, September ...
Cached Biology Technology:SulphCo Adds New Board Member 2Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited) 2Volcano Presentation at Thomas Weisel Conference to Be Webcast 2
(Date:7/22/2014)... Rochelle, NY -- Stem cells offer much promise for ... approaches stem cell survival is poor, limiting their effectiveness. ... the survival and optimize their therapeutic function after transplantation, ... Open Access , a peer-reviewed journal from Mary Ann ... the BioResearch Open Access website . ...
(Date:7/22/2014)... point, most kids will hear that drinking milk helps make their ... do these messages foster the idea that if something is good ... study in the Journal of Consumer Research , when children ... eat it. , "We predicted that when food is presented to ... a goal such as learning how to read or count, they ...
(Date:7/22/2014)... July 22, 2014 BGI Tech Solutions Co., ... world,s largest genomics organization, announced today the global ... service based on Complete Genomics, industry-leading platform. This ... SNP validation, and is available at reduced prices ... highly regarded in the industry for providing proprietary ...
Breaking Biology News(10 mins):BGI Tech launches human whole exome sequencing service on complete genomics' advanced platform 2
... chemical used to make food-storage containers, car bumpers and ... is the first definitive detection of the plastic ingredient ... A small amount of propylene was identified in Titan,s ... instrument measures the infrared light, or heat radiation, emitted ...
... Sept. 30, 2013 UC Irvine scientists Aaron Esser-Kahn, ... of the prestigious 2013 National Institutes of Health Director,s ... supports projects by early-career researchers that show potential to ... into new ways to improve human health. Esser-Kahn, ...
... ovarian cancer that has recurred after chemotherapy have survived for ... to new results to be presented today (Monday) at the ... is taken in pill form, is an inhibitor of a ... essential for tumour growth, and it is the first oral ...
Cached Biology News:NASA's Cassini spacecraft finds ingredient of household plastic in space 2UCI achieves rare trifecta: 3 scientists receive New Innovator Awards 2Biological therapy with cediranib improves survival in women with recurrent ovarian cancer 2Biological therapy with cediranib improves survival in women with recurrent ovarian cancer 3
...
...
MarrowMAX Bone Marrow Medium...
Sprague-Dawley rats, 7-8 weeks old, mixed gender; tissue is collected fresh, frozen on dry ice within minutes of sacrifice and stored at -20C; individual tissue weight approx. 0.05 gram....
Biology Products: